Sieh, Weiva3; Köbel, Martin3; Longacre, Teri A3; Bowtell, David D3; deFazio, Anna3; Goodman, Marc T3; Høgdall, Estrid5; Deen, Suha3; Wentzensen, Nicolas3; Moysich, Kirsten B3; Brenton, James D3; Clarke, Blaise A3; Menon, Usha3; Gilks, C Blake3; Kim, Andre3; Madore, Jason3; Fereday, Sian3; George, Joshy3; Galletta, Laura3; Lurie, Galina3; Wilkens, Lynne R3; Carney, Michael E3; Thompson, Pamela J3; Matsuno, Rayna K3; Kjær, Susanne Krüger5; Jensen, Allan6; Høgdall, Claus5; Kalli, Kimberly R3; Fridley, Brooke L3; Keeney, Gary L3; Vierkant, Robert A3; Cunningham, Julie M3; Brinton, Louise A3; Yang, Hannah P3; Sherman, Mark E3; García-Closas, Montserrat3; Lissowska, Jolanta3; Odunsi, Kunle3; Morrison, Carl3; Lele, Shashikant3; Bshara, Wiam3; Sucheston, Lara3; Jimenez-Linan, Mercedes3; Driver, Kristy3; Alsop, Jennifer3; Mack, Marie3; McGuire, Valerie3; Rothstein, Joseph H3; Rosen, Barry P3; Bernardini, Marcus Q3; Mackay, Helen3; Oza, Amit3; Wozniak, Eva L3; Benjamin, Elizabeth3; Gentry-Maharaj, Aleksandra3; Gayther, Simon A3; Tinker, Anna V3; Prentice, Leah M3; Chow, Christine3; Anglesio, Michael S3; Johnatty, Sharon E3; Chenevix-Trench, Georgia3; Whittemore, Alice S3; Pharoah, Paul D P3; Goode, Ellen L3; Huntsman, David G3; Ramus, Susan J3
1 Section of Gynaecology, Obstetrics and Paediatrics, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Københavns Universitet2 Department of Clinical Medicine, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Københavns Universitet3 unknown4 Department of Public Health, Faculty of Health and Medical Sciences, Københavns Universitet5 Department of Clinical Medicine, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Københavns Universitet6 Department of Public Health, Faculty of Health and Medical Sciences, Københavns Universitet
an Ovarian Tumor Tissue Analysis consortium study
Few biomarkers of ovarian cancer prognosis have been established, partly because subtype-specific associations might be obscured in studies combining all histopathological subtypes. We examined whether tumour expression of the progesterone receptor (PR) and oestrogen receptor (ER) was associated with subtype-specific survival.
Lancet Oncology, 2013, Vol 14, Issue 9, p. 853-862